ArticleTranslational oncology2026

Corrigendum to "Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations" [Translational Oncology 58 (2025) 102467].

Jie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.